Skip to main content

Antipsychotic Drugs

Volume 407: debated on Thursday 19 June 2003

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Secretary of State for Health whether his Department has commissioned a study of the long-term financial costs of (a) implements and (b) not implements the NICE recommendations in Technology Appraisal No. 43 for the use of modern antipsychotic drugs for the treatment of schizophrenia. [119207]

The Department has no plans to commission a study on the cost implications of the implementation of the schizophrenia guidance. The National Health Service has been provided with sufficient funds to implement all National Institute for Clinical Excellence (NICE) appraisal guidance as it is expected that the following of the best clinical practices, suggested by NICE, may result in an increase in cost.